Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 451 AL 465

Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer's Disease: A Six-Month, Open-Label, Observational Study

Padovani A, Caratozzolo S, Benussi A, Galli A, Rozzini L, Cosseddu M, Turrone R, Pilotto A.

J Prev Alzheimers Dis. 2024;11(2):375-381. doi: 10.14283/jpad.2023.132.

Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease

Fleisher AS, Munsie LM, Perahia DGS, Andersen SW, Higgins IA, Hauck PM, Lo AC, Sims JR, Brys M, Mintun M; PERISCOPE-ALZ Site Investigators.

Neurology. 2024 Mar 12;102(5):e208061. doi: 10.1212/WNL.0000000000208061. Epub 2024 Feb 22.

Diagnosing epileptic seizures in patients with Alzheimer's disease and deciding on the appropriate treatment plan

Brigo F, Lattanzi S.

Expert Rev Neurother. 2024 Apr;24(4):361-370. doi: 10.1080/14737175.2024.2325038. Epub 2024 Mar 1.

Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review

Rossi E, Marrosu F, Saba L.

J Alzheimers Dis. 2024;98(1):33-51. doi: 10.3233/JAD-230852.

Mitochondrial disorders leading to Alzheimer's disease-perspectives of diagnosis and treatment

Pszczołowska M, Walczak K, Miśków W, Mroziak M, Chojdak-Łukasiewicz J, Leszek J.

Geroscience. 2024 Jun;46(3):2977-2988. doi: 10.1007/s11357-024-01118-y. Epub 2024 Mar 8.

[Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia]

Gavrilova SI, Kolykhalov IV, Mikhaylova NM, Ponomareva EV, Fedorova YB, Medvedev VE, Frolova VI, Gushanskaya EV, Litvinenko IV, Emelin AY, Lobzin VY, Kashin AV, Tanashyan MM, Kachanova MV, Knyazev AV, Gonik MI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(2):69-77. doi: 10.17116/jnevro202412402169.

The underlying roles and neurobiological mechanisms of music-based intervention in Alzheimer's disease: A comprehensive review

Sun L, Wang Q, Ai J.

Ageing Res Rev. 2024 Apr;96:102265. doi: 10.1016/j.arr.2024.102265. Epub 2024 Mar 12.

Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease

Zhou C, Zeng F, Yang H, Liang Z, Xu G, Li X, Liu X, Yang J.

Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):2953-2969. doi: 10.1007/s00259-024-06690-1. Epub 2024 Mar 19.

Randomized controlled trial of a positive emotion regulation intervention to reduce stress in family caregivers of individuals with Alzheimer's disease: protocol and design for the LEAF 2.0 study

Leong CA, Summers A, Grote V, Jackson K, Dowling G, Snowberg K, Cotten P, Cheung E, Yang D, Addington EL, Moskowitz JT.

BMC Geriatr. 2024 Mar 27;24(1):289. doi: 10.1186/s12877-024-04817-5.

Neuromodulation by nanozymes and ultrasound during Alzheimer's disease management

Karthika V, Badrinathan Sridharan, Nam JW, Kim D, Gyun Lim H.

J Nanobiotechnology. 2024 Mar 30;22(1):139. doi: 10.1186/s12951-024-02406-7.

Socially Assistive Robots for patients with Alzheimer's Disease: A scoping review

Karami V, Yaffe MJ, Gore G, Moon A, Abbasgholizadeh Rahimi S.

Arch Gerontol Geriatr. 2024 Aug;123:105409. doi: 10.1016/j.archger.2024.105409. Epub 2024 Mar 12.

Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective

Shukla D, Suryavanshi A, Bharti SK, Asati V, Mahapatra DK.

Curr Top Med Chem. 2024;24(19):1699-1737. doi: 10.2174/0115680266299847240328045737.

Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab

Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, Curiale GG, Tian Y, Patel D, von Rosenstiel P, von Hehn C, Salloway S, Hock C, Nitsch RM, Haeberlein SB, Sandrock A, Singhal P.

Alzheimers Dement. 2024 May;20(5):3406-3415. doi: 10.1002/alz.13755. Epub 2024 Apr 3.

Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Svensson JE, Bolin M, Thor D, Williams PA, Brautaset R, Carlsson M, Sörensson P, Marlevi D, Spin-Neto R, Probst M, Hagman G, Morén AF, Kivipelto M, Plavén-Sigray P.

BMC Neurol. 2024 Apr 4;24(1):111. doi: 10.1186/s12883-024-03596-1.

Effects of home-based and telerehabilitation exercise on mental and physical health, and disease cost in people with Alzheimer's disease: A meta-analysis

Abdullahi A, Wong TWL, Ng SSM.

Ageing Res Rev. 2024 Jun;97:102284. doi: 10.1016/j.arr.2024.102284. Epub 2024 Apr 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias